2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Recent FDA Approvals for Adjuvant HER2+ EBC: Neratinib, Pertuzumab & T-DM-1 - How Much Benefit Can Be Expected?

236 views
August 26, 2020
Comments 0
Login to view comments. Click here to Login